Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity

BJU Int. 2009 Dec;104(11):1689-92. doi: 10.1111/j.1464-410X.2009.08673.x. Epub 2009 Jul 7.

Abstract

Objective: To investigate the efficacy of intravesical liposomes against dimethyl sulphoxide (DMSO), and pentosan polysulphate (PPS) in reducing chemically induced bladder hyperactivity in rats.

Materials and methods: Bladder reflex activity of female Sprague-Dawley rats was evaluated by continuous cystometry under urethane anaesthesia (1.0 g/kg). After obtaining a control cystometrogram (CMG) with normal saline (0.04 mL/min) for 2 h, bladder hyperactivity was then induced by 1 h infusion of protamine sulphate (10 mg/mL) followed by a 1-h infusion of KCl (500 mm). Six rats each were then infused with KCl-based preparations containing either 50% DMSO, PPS (6 mg/mL), or liposomes (2 mg/mL) for 2 h. The variables measured included the intercontraction interval (ICI), pressure threshold (PT) and baseline pressure (BP).

Results: Sequential infusion of protamine sulphate/KCl induced hyperactive bladder with no significant difference in ICI, PT or BP among groups before initiating treatment. ICI was significantly increased after infusion of PPS (58.1% increase) and liposomes (156.8% increase) but there was no increase with DMSO. PT was not significantly affected by liposome infusion but slightly increased with PPS (12.4% increase). There was a large and significant increase in PT and BP with DMSO (116.5% increase) and BP largely remained unchanged after instillation with liposomes or PPS.

Conclusions: Intravesical liposomes and PPS have a beneficial effect in a bladder hyperactivity rat model, while acute instillation of DMSO does not. Intravesical liposomes were effective in doubling the ICI compared with PPS, and might be a new treatment option for bladder hyperactivity.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Intravesical
  • Animals
  • Cystitis, Interstitial / drug therapy*
  • Cystitis, Interstitial / pathology
  • Dimethyl Sulfoxide / therapeutic use
  • Drug Carriers / therapeutic use*
  • Female
  • Liposomes / therapeutic use*
  • Pentosan Sulfuric Polyester / therapeutic use
  • Protamines
  • Rats
  • Rats, Sprague-Dawley
  • Urinary Bladder, Overactive / chemically induced
  • Urinary Bladder, Overactive / drug therapy*
  • Urinary Bladder, Overactive / pathology

Substances

  • Drug Carriers
  • Liposomes
  • Protamines
  • Pentosan Sulfuric Polyester
  • Dimethyl Sulfoxide